Nouscom Company
Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Technology:
Viral Vectors
Industry:
Viral Vectors
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
5
Total Funding:
75000000
Estimated Revenue:
Less than $1M
Last Funding Date:
2017-11-06
Last Funding Type:
Series B
Register and Claim Ownership